MetaVia Inc.
MetaVia Inc. (MTVA): 7 pipeline candidates · ~10 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
9.8 months
D/E 0.59 · 0% dilution
Lead: Phase 2
7 candidates
N/A
N/A
A transparent, data-derived signal for MetaVia Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$8.5M
Cash
$13.7M
Quarterly Burn
$4.3M
Runway
9.8 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
8
Total value held
$68K
| Holder | Shares | Value |
|---|---|---|
| geode capital management, llc | 33,635 | $40K |
| jane street group, llc | 10,903 | $13K |
| vanguard fiduciary trust co | 6,940 | $8K |
| vanguard capital management llc | 4,444 | $5K |
| blackrock, inc. | 479 | $575 |
| brown brothers harriman & co | 2 | $2 |
| danske bank a/s | 2 | $2 |
| ubs group ag | 1 | $1 |
Frequently asked questions
How many drug candidates are in MetaVia Inc.'s pipeline?
MetaVia Inc. (MTVA) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is MetaVia Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, MetaVia Inc. has approximately 9.8 months of cash runway.
What is MetaVia Inc.'s market capitalization?
MetaVia Inc.'s market capitalization is approximately $8.5M.
Who is the CEO of MetaVia Inc.?
Mr. Hyung Heon Kim is the chief executive officer of MetaVia Inc. (MTVA).
Get the full picture on MetaVia Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.